A startup leveraging its proprietary language processing technology, SATOMI®, to support the automatic generation of medical records and referral letters. By streamlining information use in clinical settings, it promotes regional collaboration and medical DX, contributing to the development of a sustainable healthcare system.
[画像1: https://prtimes.jp/i/81736/10/resize/d81736-10-65ec8b9a3715fdbf1dde-0.jpg ] 医療向けAIソフトウェアの開発を行うエニシア株式会社（本社：京都市左京区、代表取締役：小東茂夫、以下、エニシア）...
[画像1: https://prtimes.jp/i/81736/9/resize/d81736-9-a0897ae7ecb1f6580270-0.jpg ] 医療向けAIソフトウェア開発を行うエニシア株式会社（本社：京都市左京区、代表取締役：小東茂夫、以下、エニシア）は、...
[画像1: https://prtimes.jp/i/81736/8/resize/d81736-8-edca2d6e9b8e1026aaa8-3.jpg ] 医療向けAIソフトウェア開発を行うエニシア株式会社（本社：京都市左京区、代表取締役：小東茂夫、以下、エニシア）は、A...
カルテ構造化APIサービスは、医療テキストを目的に応じて整理するサービスです。独自の医療言語処理技術『SATOMI(R)』を応用し、カルテなどの医療テキストを目的に応じた形に自動で整理することで、これまで利...
A startup developing a tooth regeneration drug that enables the regeneration of missing teeth in congenital anodontia by utilizing neutralizing antibodies that suppress molecules inhibiting tooth germ growth.
We are conducting clinical development of an oral therapeutic cancer vaccine. We have completed a Phase I clinical trial targeting urothelial carcinoma and are currently conducting a Phase I/IIa clinical trial for malignant pleural mesothelioma.
bacterico is a biotechnology startup developing personalized healthcare solutions based on an individual’s own gut microbiome. We isolate, select, and cultivate Bifidobacterium strains from stool samples and enhance them using proprietary culture methods to create personalized probiotic supplements optimized for each person’s gut environment. We also provide evidence-based programs tailored to key life moments, including Mama Flora, which supports maternal and infant health through prenatal gut microbiome care, and Preflora, a personalized nutrition and gut-health program designed specifically for individuals who are actively trying to conceive. Through science-driven, individualized interventions, bacterico aims to bring safe and effective microbiome-based solutions to everyday health.
Solving challenges in manufacturing, construction, and infrastructure with proprietary AI that leverages even limited data. A startup supporting operational efficiency and labor savings, aiming for a future where humans and AI coexist.
